Table: OncoTherapy Science -Q1 group results

OncoTherapy Science

05/08/2022 09:00

Aug 5 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2022        Jun 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            385 mln             93 mln                     
                (+313.9 pct)        (+127.2 pct)                  
  Operating     loss 307 mln        loss 571 mln                  
  Recurring     loss 314 mln        loss 571 mln                  
  Net           loss 277 mln        loss 534 mln                  
  EPS           loss 1.44 yen       loss 3.00 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T